Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Tonsillectomy and Adenoidectomy

Burak Omur

Status: Completed

Conditions: Postoperative Pain; Anxiety; Bleeding

Treatments: Drug: Fentanyl; Drug: Dexmedetomidine

Study type: Observational

Funder types: Other

Identifiers

NCT05986942

000030195314317

Details and patient eligibility

About

Dexmedetomidine is a drug known for its pain-relieving and restlessness-reducing effects. The purpose of this run is to use the association between this use during surgery and the attrition of post-operative pain and discomfort. In the research, laboratory and monitoring results will be obtained before, during and after the operation. Postoperative patient complaints will be evaluated at the postoperative service visit. This study is decided on a completely voluntary basis.

Enrollment: 80 patients

Sex: All

Ages: 2 to 10 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients with ASA 1-2, aged 2-10 years, scheduled for elective tonsillectomy and/or adenoidectomy operation will be included.

Exclusion criteria

developmental delay anxiety disorder Known history of allergy to alpha-2 agonistic agents use of antipsychotic medication beta blocker use of anticonvulsant drugs chronic pain syndrome with cardiac and craniofacial anomalies

Trial design

80 participants in 2 patient groups

Dex

Description:

patients using dexmedetomidine infusion

Treatment:

Drug: Dexmedetomidine

Fen

Description:

patients using fentanyl for induction

Treatment:

Drug: Fentanyl